Article

Using the Bayesian credible subgroups method to identify populations benefiting from treatment: An application to the Look AHEAD trial

2019-12-14

Abstract excerpt

Traditionally, subgroup analyses are used to assess whether patient characteristics moderate treatment effectiveness with general disregard for issues of multiplicity. Using data from The Action for Health in Diabetes (Look AHEAD) trial in the United States, we aim to identify a subgroup where all of its types of members experience a treatment benefit defined as reducing the likelihood of a major cardiovascular ev...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 97c7b805-51ed-59d1-aad7-0d9bc1b773e8
DOI: 10.1101/2019.12.10.19014357

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Using the Bayesian credible subgroups method to identify populations benefiting from treatment: An application to the Look AHEAD trialDOI 10.1101/2019.12.10.19014357Read

On Bayesian methods of exploring qualitative interactions for targeted treatment.Semantic proximity Read

Heterogeneity of Treatment Effects Across Nine Glucose-Lowering Drug Classes in Type 2 Diabetes: Extension of the LEGEND-T2DM Network StudySemantic proximity Read

The Call for Progress in Evidence-Based MedicineSemantic proximity Read

Revisiting the High-Benefit Patient: Generic Machine Learning Inference for Intensive Blood Pressure ControlSemantic proximity Read

In silico study of medical decision-making for rare diseases: heterogeneity of decision-makers in a population improves overall benefitSemantic proximity Read

Applications of Bayesian Shrinkage Prior Models in Clinical Research with Categorical ResponsesSemantic proximity Read

Health dialogue intervention versus opportunistic screening in primary care for type 2 diabetes and cardiovascular disease prevention in settings with low socioeconomic status (DETECT): study protocol for a pragmatic cluster-randomized trialSemantic proximity Read

Stages of behavioural change after direct-to-consumer disease risk profiling: study protocol of two integrated controlled pragmatic trials.Semantic proximity Read

Target trial emulation for a two-arm, parallel, stratified pragmatic RCT of CABG versus PCI in people with high-risk characteristics requiring myocardial revascularisation (High-Risk REVASC)Semantic proximity Read

Statistical power considerations in genotype-based recall randomized controlled trials.Semantic proximity Read

Heterogeneous causal mediation analysis using Bayesian additive regression trees.Semantic proximity Read

Statistical Considerations for the Design and Analysis of Pragmatic Trials in Aging ResearchSemantic proximity Read